After trial data for a new medicine proved inconclusive, Sarepta Therapeutics joined with the parents of sick boys to persuade officials it helped.

Topics:  sarepta therapeutics   
BING NEWS:
  • How the FDA Approved a $300,000-a-Year Drug Its Own Experts Didn’t Believe Worked
    Jennifer McNary, a stay-at-home mother, was desperate to find a medicine that might spare her two sons an early death from a rare form of muscular dystrophy. Chris Garabedian, the chief executive of a pharmaceutical firm, was desperate to find a profitable ...
    05/19/2017 - 8:11 am | View Link
  • FDA clears new ALS drug for US market
    The Food and Drug Administration has approved Radicava (edaravone) in the U.S. as the first new drug in two decades to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. This will be marketed by MT Pharma America, a division ...
    05/8/2017 - 2:47 am | View Link
  • Eteplirsen Approval Seen as Marking New Direction at FDA
    "She approved a drug not realizing that by approving the drug based on evidence that was so obviously inadequate many health insurance companies would just refuse to pay for it." Without insurance coverage, families have to pay $300,000 a year for the drug.
    12/28/2016 - 3:01 am | View Link
  • To appease a patient lobby, did the FDA approve a $300,000 drug that doesn't work?
    A couple of weeks ago, the big insurance company Anthem decided that it wouldn’t pay for Exondys 51, a drug that already had been approved by the Food and ... The drug costs $300,000 a year, and the evidence that it works is almost laughably thin.
    10/28/2016 - 9:06 am | View Link
  • ‘Tough as nails’: Storm swirls around FDA drug cop who approved controversial drug
    But after parsing the data, the FDA’s scientific experts said there was ... that the Duchenne muscular dystrophy drug is safe. If it doesn’t work, why should patients and insurers pay an estimated $300,000 a year for it? “The bigger risk is not ...
    09/19/2016 - 10:13 pm | View Link
  • More
BING SEARCH:
  • How the fda approved a $300,000-a-year drug its ow ...
    How the fda approved a $300,000-a-year drug its own experts didn’t believe ... How the fda approved a $300,000-a-year drug its own experts didn’t believe worked ...
    05/27/2017 - 4:19 am | View Website
  • How the FDA Approved a $300,000-a-Year Drug Its Own ...
    How the FDA Approved a $300,000-a-Year Drug Its Own Experts Didn t Believe Worked ... Experts | Didn | Believe | Most Popular (6 hours)
    05/25/2017 - 10:51 pm | View Website
  • How the FDA Approved a $300,000-a-Year Drug Its Own ...
    How the FDA Approved a $300,000-a-Year Drug Its Own Experts Didn't Believe Worked. ... 2017 FDA Approves New Drug to Treat ALS World News - 20:17 PM GMT May 17, ...
    05/22/2017 - 12:00 am | View Website
  • How the FDA Approved a $300,000-a-Year Drug Its Own ...
    How the FDA Approved a $300,000-a-Year Drug Its Own Experts Didn’t Believe Worked. Shared by Matt Fisher via Twitter | 483 180 9 | about 6 hours ago.
    05/19/2017 - 4:17 pm | View Website
  • How the FDA approved a $300,000-a-year drug its own ...
    How the FDA approved a $300,000-a-year drug its own experts didn’t believe worked. The Wall Street Journal, May 19, ...
    05/19/2017 - 9:29 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News